Literature DB >> 18164922

Psychometric testing and validation of the Chronic Pain Sleep Inventory.

Mark Kosinski1, Carmela C Janagap, Kavita Gajria, Jeff Schein.   

Abstract

BACKGROUND: Patients with chronic pain often experience significant disruptions in sleep. A potential benefit of treatment aimed at pain relief is improved quality of sleep in patients with chronic pain.
OBJECTIVE: The goal of this study was to evaluate the psychometric properties of the Chronic Pain Sleep Inventory (CPSI) and provide preliminary evidence of its construct validity in assessing sleep problems among patients with chronic pain.
METHODS: Data came from four 12-week, multi-center, double-blind, randomized, placebo-controlled clinical trials of chronic low back pain and osteo-arthritis of the hip or knee. CPSI data were collected at baseline and 12 weeks. The 5 CPSI items measured trouble falling asleep (CPSI1), needing sleep medication (CPSI2), awakened by pain during the night (CPSI3) and in the morning (CPSI4), and overall quality of sleep (CPSI5) on a 100-mm visual analog scale. Exploratory and confirmatory factor analyses were conducted to evaluate the underlying dimensionality and structure of the CPSI scales. The known-groups method was used to assess validity by comparing CPSI item scores across groups of patients known to differ in the presence and severity of sleep problems as measured by the Physical Dependence Questionnaire.
RESULTS: A total of 2674 patients were included in the study (mean age, 57.6 years; 61.0% female; 80.2% white). The majority of the patients were treated for chronic pain related to osteoarthritis of the hip or knee (n=2294). Findings revealed a single sleep problems index can be scored from 3 of the 5 CPSI items (CPSI1, CPSI3, and CPSI4). All 3 items attributed sleep problems to pain, with high factor loadings (>0.80) and a high internal consistency (>0.90). Moderate to high correlations (r >or= 0.50) between CPSI items demonstrated convergent validity, and weak correlations (r<0.50) with other health-related scales (the Western Ontario and McMaster Universities Osteo-arthritis Index and the 36-item Short-Form Health Survey) demonstrated discriminant validity. All CPSI items showed greater ability to discriminate and respond to changes in the presence and severity of sleep problems than the other health-related scales.
CONCLUSIONS: CPSI items showed good construct validity, and the results support the scoring of a reliable single index from 3 of the 5 CPSI items that all attributed sleep problems to pain.

Entities:  

Mesh:

Year:  2007        PMID: 18164922     DOI: 10.1016/j.clinthera.2007.12.001

Source DB:  PubMed          Journal:  Clin Ther        ISSN: 0149-2918            Impact factor:   3.393


  12 in total

1.  Randomized control trial of topical clonidine for treatment of painful diabetic neuropathy.

Authors:  Claudia M Campbell; Mark S Kipnes; Bruce C Stouch; Kerrie L Brady; Margaret Kelly; William K Schmidt; Karin L Petersen; Michael C Rowbotham; James N Campbell
Journal:  Pain       Date:  2012-06-08       Impact factor: 6.961

2.  The Pain and Sleep Questionnaire three-item index (PSQ-3): a reliable and valid measure of the impact of pain on sleep in chronic nonmalignant pain of various etiologies.

Authors:  Lindsay Ayearst; Zoltan Harsanyi; Kenneth J Michalko
Journal:  Pain Res Manag       Date:  2012 Jul-Aug       Impact factor: 3.037

3.  Design considerations for a remote randomized multi-site clinical trial evaluating an e-health self-management program for chronic pain patients receiving opioid therapy.

Authors:  Theresa Winhusen; Marian Wilson; Rowena J Dolor; Jeff Theobald; Daniel Lewis; Saundra L Regan; Mary Beth Vonder Meulen
Journal:  Contemp Clin Trials       Date:  2020-12-10       Impact factor: 2.226

4.  Multicomponent interdisciplinary group intervention for self-management of fibromyalgia: a mixed-methods randomized controlled trial.

Authors:  Patricia Bourgault; Anaïs Lacasse; Serge Marchand; Roxanne Courtemanche-Harel; Jacques Charest; Isabelle Gaumond; Juliana Barcellos de Souza; Manon Choinière
Journal:  PLoS One       Date:  2015-05-15       Impact factor: 3.240

5.  Pharmacotherapeutic management of chronic noncancer pain in primary care: lessons for pharmacists.

Authors:  Ghaya Jouini; Manon Choinière; Elisabeth Martin; Sylvie Perreault; Djamal Berbiche; David Lussier; Eveline Hudon; Lyne Lalonde
Journal:  J Pain Res       Date:  2014-03-24       Impact factor: 3.133

6.  Costs of moderate to severe chronic pain in primary care patients - a study of the ACCORD Program.

Authors:  Lyne Lalonde; Manon Choinière; Elisabeth Martin; Djamal Berbiche; Sylvie Perreault; David Lussier
Journal:  J Pain Res       Date:  2014-07-07       Impact factor: 3.133

7.  Development and Implementation of a Registry of Patients Attending Multidisciplinary Pain Treatment Clinics: The Quebec Pain Registry.

Authors:  M Choinière; M A Ware; M G Pagé; A Lacasse; H Lanctôt; N Beaudet; A Boulanger; P Bourgault; C Cloutier; L Coupal; Y De Koninck; D Dion; P Dolbec; L Germain; V Martin; P Sarret; Y Shir; M-C Taillefer; B Tousignant; A Trépanier; R Truchon
Journal:  Pain Res Manag       Date:  2017-02-09       Impact factor: 3.037

8.  Quebec Serve and Protect Low Back Pain Study: What About Mental Quality of Life?

Authors:  Nabiha Benyamina Douma; Charles Côté; Anaïs Lacasse
Journal:  Saf Health Work       Date:  2018-09-06

9.  Efficacy and tolerability of oral oxycodone and oxycodone/naloxone combination in opioid-naïve cancer patients: a propensity analysis.

Authors:  Marzia Lazzari; Maria Teresa Greco; Claudio Marcassa; Simona Finocchi; Clarissa Caldarulo; Oscar Corli
Journal:  Drug Des Devel Ther       Date:  2015-11-02       Impact factor: 4.162

10.  Cebranopadol, a novel first-in-class analgesic drug candidate: first experience in patients with chronic low back pain in a randomized clinical trial.

Authors:  Annette Christoph; Marie-Henriette Eerdekens; Maurits Kok; Gisela Volkers; Rainer Freynhagen
Journal:  Pain       Date:  2017-09       Impact factor: 7.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.